EUVIMEDEUVIMED entdecken
Crossref

RING Finger Protein 4 ( RNF4 ) Reduces Nonalcoholic Fatty Liver Disease Accumulation by Promoting the SUMOylation of HIF ‐2α and Regulating the PPARα Signaling Pathway

Li Yang iD, Qing Ni, Yan He, Shijie Liu, Lulu Gan, Anni Dai, Yang Hu, Qian Liu, Xueling Yang, Jiqian Li, Yi Tao, Yunyu Li und 1 weitere

IUBMB Life · 2025

DOI: 10.1002/iub.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Li Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension Center, Yan'an Hospital Affiliated to Kunming Medical University Kunming Technical Diagnosis and Treatment Center for Refractory Hyperte…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Basic Helix-Loop-Helix Proteins, PPAR alpha, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Yunnan province ten thousand people plan project, Science and Technology Talent and Platform Program (Academician and Expert Workstation), Science and technology Plan project of Science and Technology Department of Yunnan Province-Major science and technology Special plan-Biomedicine special Proje….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RING finger protein 4 (RNF4) acts as a SUMO‐targeted ubiquitin ligase, principally regulating protein stability and playing a crucial role in liver injury, inflammatory, and cholestatic diseases. In spite of this, it is unclear how it contributes to nonalcoholic fatty liver disease (NAFLD). The rat model of NAFLD was constructed by feeding a high‐fat diet (HFD), and HepG2 cells were treated with 1 mmol/L oleic acid (OA) for 24 h. Real‐time quantitative polymerase chain reaction (RT‐qPCR) and western blotting were used to measure the expression of associated genes and proteins. Oil red O staining, enzyme‐linked immunosorbent assay (ELISA), flow cytometry, and hematoxylin–eosin (HE) staining were used to assess damage to HepG2 cells and rat liver tissues. RNF4 expression is reduced in NAFLD. Overexpression of RNF4 in HepG2 cells reduced triglyceride (TG) and total cholesterol (TC) levels and increased high density lipoprotein cholesterol (HDL‐C) levels. In addition, overexpression of RNF4 suppressed lipogenic genes liver X receptor alpha (LXRα), fatty acid synthase (FAS), stearoyl‐CoA desaturase‐1 (SCD1), and cytochrome P4A11 (Cyp4a11), inflammatory cytokines tumor necrosis factor‐alpha (TNF‐α), interleukin‐1beta (IL‐1β), and interleukin‐6 (IL‐6), and cell apoptosis; it also inhibited lipid accumulation in vivo and improved liver tissue pathology, thereby mitigating NAFLD progression. Mechanistically, RNF4 promotes SUMOylation and ubiquitin‐mediated degradation of hypoxia inducible factor‐2 alpha (HIF‐2α), thereby enhancing peroxisome proliferator‐activated receptor alpha (PPARα) expression, reducing lipid accumulation, inflammation, and cell apoptosis, ultimately alleviating NAFLD development. Our research indicates that RNF4 may be a novel therapeutic target for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseBasic Helix-Loop-Helix ProteinsPPAR alphaTranscription FactorsHumansAnimalsRatsHep G2 CellsSignal TransductionSumoylationMaleDiet, High-FatLiverRats, Sprague-DawleyNuclear ProteinsEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

RING finger protein 4 (RNF4)SUMOylationhypoxia inducible factor‐2 alpha (HIF‐2α)nonalcoholic fatty liverperoxisome proliferator‐activated receptor alpha (PPARα)

Substanzen

Basic Helix-Loop-Helix ProteinsPPAR alphaTranscription FactorsNuclear ProteinsEndothelial PAS Domain-Containing Protein 1RNF4 protein, humanPPARA protein, human

Autor:innen und Institutionen

  • Hypertension Center, Yan'an Hospital Affiliated to Kunming Medical University Kunming Technical Diagnosis and Treatment Center for Refractory Hypertension, Kunming, China.
  • Hypertension Center, Kunming Technical Diagnosis and Treatment Center for Refractory Hypertension, Kunming, China.
  • Hypertension Center, Kunming Yan'an Hospital Cardiac Rehabilitation Center, Kunming, China.

ORCID-Profile: Li Yang

Förderung

  • Yunnan province ten thousand people plan project
  • Science and Technology Talent and Platform Program (Academician and Expert Workstation)
  • Science and technology Plan project of Science and Technology Department of Yunnan Province-Major science and technology Special plan-Biomedicine special Proje…
  • Key Laboratory of Cardiovascular Disease of Yunnan Province

Zitieren

APA

Yang, L., Ni, Q., He, Y., Liu, S., Gan, L., Dai, A., Hu, Y., Liu, Q., Yang, X., Li, J., Tao, Y., Li, Y., & Xu, M. (2025). RING Finger Protein 4 ( RNF4 ) Reduces Nonalcoholic Fatty Liver Disease Accumulation by Promoting the SUMOylation of HIF ‐2α and Regulating the PPARα Signaling Pathway. IUBMB Life. https://doi.org/10.1002/iub.70047

Vancouver

Yang L, Ni Q, He Y, Liu S, Gan L, Dai A, et al. RING Finger Protein 4 ( RNF4 ) Reduces Nonalcoholic Fatty Liver Disease Accumulation by Promoting the SUMOylation of HIF ‐2α and Regulating the PPARα Signaling Pathway. IUBMB Life. 2025. doi:10.1002/iub.70047

BibTeX
@article{Yang2025,
  author = {Yang, Li and Ni, Qing and He, Yan and Liu, Shijie and Gan, Lulu and Dai, Anni and Hu, Yang and Liu, Qian and Yang, Xueling and Li, Jiqian and Tao, Yi and Li, Yunyu and Xu, Mingyue},
  title = {RING Finger Protein 4 ( RNF4 ) Reduces Nonalcoholic Fatty Liver Disease Accumulation by Promoting the SUMOylation of HIF ‐2α and Regulating the PPARα Signaling Pathway},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.70047}
}
Kostenlos starten →